Type(s) of Cancer
Leukemia/Lymphoma
Leukemia/Lymphoma
Study Phase
Phase 3
Study Completion Date
2007-06
2007-06
NCT00085124Uploaded 05-25-2024
Access via NCI by Request
PDS UID: nci-data-544
A Phase III Study of Daunorubicin and Cytarabine +/- G3139 (Genasense, Oblimersen Sodium, NSC #683428, IND #58842), a BCL2 Antisense Oligodeoxynucleotide, in Previously Untreated Patients With Acute Myeloid Leukemia (AML) > / = 60 Years
Files: NCT00085124-D1![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-csv.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
Data DictionaryNCT00085124-D1-Data-Dictionary_1.pdf
![](/projectdatasphere/Images/icons/icon-csv.png)
DATANCT00085124-D1-Dataset_1.csv
![](/projectdatasphere/Images/icons/icon-pdf.png)
OTHERREADME.pdf
Files: NCT00085124-D2![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-csv.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
![](/projectdatasphere/Images/icons/icon-pdf.png)
Data DictionaryNCT00085124-D2-Data-Dictionary_1.pdf
![](/projectdatasphere/Images/icons/icon-csv.png)
DATANCT00085124-D2-Dataset_1.csv
![](/projectdatasphere/Images/icons/icon-pdf.png)
OTHERREADME.pdf